One could speculate that a key treatment strategy for progressive MS could involve targeting CNS-resident B cells, not aiming to suppress their traditional immunological (mis)behavior, but instead to quell a yet-to-be-discovered unconventional action, possibly related to secretion of an MS-specific myelin toxin into the CSF
Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling ( 2 H, 15 N, and 13 C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc
Before diving into the science, it helps to understand the basics
326 ( Pt 1) : p
Define the topic in consumer-safe language first